Shares of Imperva Inc (NYSE:IMPV) have been assigned a consensus rating of “Buy” from the twenty research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and ten have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $49.03.

Several equities analysts have commented on IMPV shares. Monness Crespi & Hardt started coverage on shares of Imperva in a research report on Tuesday, March 14th. They set a “buy” rating and a $52.00 target price on the stock. Evercore ISI reissued a “buy” rating and set a $56.00 target price on shares of Imperva in a research report on Monday, May 15th. Susquehanna Bancshares Inc started coverage on shares of Imperva in a research report on Wednesday, June 7th. They set a “positive” rating and a $60.00 target price on the stock. TheStreet raised shares of Imperva from a “d” rating to a “c” rating in a research report on Thursday, May 4th. Finally, DA Davidson reissued a “buy” rating and set a $55.00 target price on shares of Imperva in a research report on Wednesday, March 22nd.

In related news, insider Amichai Shulman sold 3,085 shares of the stock in a transaction dated Monday, April 17th. The shares were sold at an average price of $41.97, for a total value of $129,477.45. Following the completion of the sale, the insider now owns 99,151 shares in the company, valued at $4,161,367.47. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CRO Michael D. Mooney sold 52,356 shares of the stock in a transaction dated Wednesday, May 10th. The shares were sold at an average price of $47.51, for a total transaction of $2,487,433.56. Following the completion of the sale, the executive now owns 52,356 shares of the company’s stock, valued at approximately $2,487,433.56. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 63,387 shares of company stock worth $3,005,338. 2.20% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in IMPV. Ameritas Investment Partners Inc. bought a new stake in Imperva during the first quarter valued at $102,000. KCG Holdings Inc. bought a new stake in Imperva during the first quarter valued at $201,000. Seven Eight Capital LP bought a new stake in Imperva during the fourth quarter valued at $207,000. US Bancorp DE boosted its stake in Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock valued at $221,000 after buying an additional 3,163 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in Imperva during the first quarter valued at $224,000. Institutional investors and hedge funds own 92.72% of the company’s stock.

Shares of Imperva (NYSE IMPV) remained flat at $49.40 on Tuesday. The stock had a trading volume of 927,715 shares. The stock’s market cap is $1.65 billion. The stock has a 50 day moving average of $48.62 and a 200 day moving average of $43.04. Imperva has a 1-year low of $34.40 and a 1-year high of $57.24.

Imperva (NYSE:IMPV) last posted its earnings results on Thursday, May 4th. The software maker reported ($0.29) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.62) by $0.33. The firm had revenue of $72.31 million for the quarter, compared to the consensus estimate of $68.16 million. Imperva had a net margin of 31.92% and a return on equity of 36.67%. The business’s quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.25) earnings per share. On average, equities research analysts anticipate that Imperva will post $0.45 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Imperva Inc (IMPV) Receives $49.03 Average Price Target from Analysts” was first published by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/imperva-inc-impv-receives-49-03-average-price-target-from-analysts/1389300.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.